It turned out that cancers from virtually all responders carried by then unknown intragenic mutation in EGFR gene, while non-responders were characterized by the wild-type EGFR sequence (Lynch et al., 2004; Paez et al., 2004; Pao et al., 2004). Here, EGFR is linked to cancer.